Website intended for a NZ health professional readership
Last year, cilazapril with hydrochlorothiazide was discontinued, and now cilazapril alone is no longer funded for new patients. Consultant cardiologist Chris Ellis discusses what to do when patients with hypertension run out of their supply of these medications
Messerli FH, Bangalore S, Bavishi C, et al. Angiotensinconverting enzyme inhibitors in hypertension: To use or not to use? J Am Coll Cardiol 2018;71(13):1474–82.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
